TrialBMC medicine2025

Induction chemotherapy plus camrelizumab combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma in non-endemic areas: a phase 2 clinical trial in North China.

Zhongqiu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.